Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Piotr Mrozek has a total of 39 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Rolling motion of water inside droplet in electrowetting-on-dielectric experiment

    by Romuald Mosdorf, Piotr Mrozek, Gabriela Rafałko, Adam Adamowicz


  • Open Access

    Digitalisation of Painting Path Topography for Numerical Modelling of Low-Relief Surfaces

    by Andrzej Werner, Bogusław HOŚCIŁO, Piotr Mrozek, Krzysztof Molski

    The methodology presented in this article involves the digitalization of painting path topography created using various brushes on different canvases. Measurements were conducted using a blue structured light scanner. Preliminary test scans were performed to determine the optimal digitalization parameters, including exposure time, number of exposures, and scanning resolution. A resolution of 0.08 mm was selected as the minimum point spacing, which was sufficient for both modelling and application use. This scanning process enabled the capture of surface deformations, including path fading and topographic variations arising from interactions between brush bristles, paint, and the canvas substrate—even in cases of partial paint coverage. The resulting 3D model was integrated into an application designed to replicate the glazing technique in painting.

  • Open Access

    A Study on the Levels of Selected Proangiogenic Proteins in Human Tissues and Plasma in Relation to Brain Glioma

    by Zuzanna Zielinska, Julia Giełażyn, Zofia Dzieciol-Anikiej, Janusz Dzieciol, Piotr Mrozek, Joanna Reszec-Gielazyn, Ewa Gorodkiewicz

    Brain glioma is one of the most common malignant tumors of brain tissue. It is characterized by rich vascularization, which indicates the significant participation of angiogenesis in its growth and development. In its first stages, the disease is very often asymptomatic, and late diagnosis significantly limits possibilities of treatment. Tumor angiogenesis, i.e., the formation of new vessels, requires the presence of angiogenic compounds that will enable tumor progression by creating a path for the supply of nutrients. The proangiogenic compounds involved in the development of glioma include hypoxia-inducible factor 1α (HIF-1α), angiopoietin-2 (ANG-2), and interleukin-1β (IL-1β). The aim of this study was to analyze changes in the levels of these proteins in plasma samples of patients diagnosed with brain glioma in stages G1 to G4, and in a control group, using SPRi biosensors. The results obtained in plasma were compared with the concentrations obtained during the analysis of tissue homogenates from patients with glioma in stages G2 to G4. A statistically significant difference in plasma concentrations was obtained between the patient group and the control group. The concentrations of the markers in tissue homogenate samples were statistically higher than in blood plasma. There was no significant effect of gender, diet, smoking, or the patient’s general health condition (Karnofsky score) on the course of the disease. These factors do not directly increase the risk of developing brain glioma.


  • Open Access

    Comparison of Fluidic and Non-Fluidic Surface Plasmon Resonance Biosensor Variants for Angular and Intensity Modulation Measurements

    by Piotr Mrozek, Lukasz Oldak, Ewa Gorodkiewicz

    Fluidic and non-fluidic surface plasmon resonance measurements were realized for the same type of sensory layer and using the same mouse IgG antibody and anti-mouse IgG antibody biomolecular system. A comparison of the thicknesses of the anti-mouse IgG antibody layers bound to the ligand at increasing analyte concentrations ranging from 0.0 μg mL−1 to 5.0 μg mL−1 in the non-fluidic and the fluidic variant showed that the thickness of the bound anti-mouse antibody layers in the fluidic variant was approximately 1.5–3 times larger than in the non-fluidic variant. The greater thicknesses of the deposited layers were also reflected in the larger increment of the resonant angle in the fluidic variant compared to the non-fluidic variant in the considered range of analyte concentrations. The choice between fluidic and non-fluidic surface plasmon resonance biosensors may be justified by the availability of analyte volume and the intended modulation technique. When working with limited analyte, non-fluidic biosensors with intensity modulation are more advantageous. For larger analyte quantities, fluidic biosensors with angular modulation are recommended, primarily due to their slightly higher sensitivity in this measurement mode.


  • Open Access

    Finite Element Model of Scoliosis Brace with Increased Utility Characteristics

    by Slawomir Grycuk, Piotr Mrozek

    Orthoses are of critical importance in the field of medical biomechanics, particularly in the correction of spinal deformities. The objective of the current research was to improve the utility characteristics of the scoliosis brace without compromising its corrective capabilities. The orthotic shell of the Boston brace was used as the basis for this investigation. The finite element method (FEM) was used to evaluate the distribution of corrective forces through the device. The flow of force lines within the orthotic shell was determined by mapping the paths of maximum principal stresses. Areas of the device that had a negligible effect on overall stiffness were identified and material from these areas was eliminated. Minor modifications were then made to the redesigned shell to maintain its corrective stiffness. As a result of these changes, the weight of the braces was reduced without compromising its corrective stiffness. When subjected to corrective forces, the shell’s displacement patterns in the transverse plane showed minimal changes from the original model, confirming that its corrective capacity remained largely intact. This research presents an innovative methodology for orthotic design and demonstrates that structural optimization based on the mapping of maximum principal stress pathways can significantly improve device functionality. The approach outlined here holds promise for future advances in the design of various orthotic devices, thereby contributing to the advancement of the field.


  • Open Access

    Two Biosensors for the Determination of VEGF-R2 in Plasma by Array SPRi

    by Lukasz Oldak, Beata Zelazowska-Rutkowska, Anna Lesniewska, Piotr Mrozek, Marcin Skoczylas, Zenon Lukaszewski, Ewa Gorodkiewicz

    Vascular endothelial growth factor receptor 2 (VEGF-R2) is a marker of angiogenesis and metastasis of cancer. Two biosensors for the determination of VEGF-R2 in plasma have been developed. One of them is based on a pure gold chip, and the other on a silver/gold bimetallic chip; both have the receptor, monoclonal rabbit antibody specific for human VEGF-R2, attached to the chip via a cysteamine linker. The biosensor with the gold chip exhibits linearity of the analytical signal between 0.03 and 2 ng/mL, a precision of 1.4% and recovery between 99% and 102%. The biosensor with the bimetallic chip exhibits linearity between 0.03 and 1 ng/mL, a precision of 2.2% and recovery between 99% and 103%. Both biosensors tolerate a 1:100 excess of VEGF, VEGF-R1 and VEGF-R3. Both biosensors were validated by parallel determination of VEGF-R2 in 27 different plasma samples using the ELISA immunosensor assay, with very good agreement of the results. Thermodynamic parameters of the interaction of VEGF-R2 with the antibody were determined by QCM (Quartz Crystal Microbalance) and SPRi (Surface Plasmon Resonance imaging) measurements.


  • Open Access

    Scoliosis Brace Finite Element Model and Preliminary Experimental Testing Using Electronic Speckle Pattern Interferometry

    by Slawomir Grycuk, Piotr Mrozek

    This article presents the results of numerical finite element method (FEM) simulations in the Ansys environment of a Boston orthopaedic brace. The geometric model was developed based on the results of digitisation performed by means of a three-dimensional (3D) optical scanner. A test stand for measurement of the brace’s field of displacements, utilising a laser electronic speckle pattern interferometer (ESPI), was used to experimentally verify the FEM model. During experimental testing, special attention was given to applying the loads and boundary conditions used in the numerical simulations. As a result, the relative difference between the experimentally and numerically determined displacements in the central part of orthoses amounted to approximately 0.6%. The experimentally verified FEM model was used to determine the force flow lines characteristic of the brace, indicating the general working method of the brace’s structure. The primary parts of the orthoses, carrying loads correcting the spine and the position of sites exerting little effort from the perspective of their participation in the orthoses’ essential therapeutic application were identified. The results obtained allow for the proposal of methods for mechanical optimisation of the brace’s design. The analysis conducted is universal in nature and can be adapted to other types of orthopaedic braces.


  • Open Access

    A Comparison of Various Chips Used for the Manufacture of Biosensors Applied in Non-Fluidic Array SPRi, Based on the Example of Determination of Cathepsin D

    by Pawel Falkowski, Piotr Mrozek, Piotr Miluski, Zenon Lukaszewski, Ewa Gorodkiewicz

    Non-fluidic array SPR imaging (SPRi) with appropriate biosensors is a new tool for the determination of various biomarkers in body fluids. Numerous biomarkers can be determined without signal enhancement or preliminarily preconcentration. The introduction of a new material solution of the chip may increase the scope of the application of this technique. Solutions with adhesive separating foil and an Ag/Au chip were compared with the previously used two-paint separating polymer and pure gold chip. These solutions were tested using the example of a biosensor for cathepsin D (Cath D), which consisted of pepstatin A (a Cath D inhibitor) immobilized via a cysteamine linker using the NHS/EDC protocol. Four material versions of the Cath D biosensor proved adequate in terms of range of linearity, LOQ, precision and recovery. All four versions of the biosensor were used for the determination of Cath D in the blood serum patients with glioblastoma and control samples, producing very similar results and showing an elevated biomarker concentration in the case of cancer. Therefore, the problem of determining the correct level of Cath D in the serum of healthy individuals has been resolved, correcting literature data which ranged over three orders of magnitude.


  • Open Access

    An Immunosensor for the Determination of Cathepsin S in Blood Plasma by Array SPRi—A Comparison of Analytical Properties of Silver–Gold and Pure Gold Chips

    by Pawel Falkowski, Piotr Mrozek, Zenon Lukaszewski, Lukasz Oldak, Ewa Gorodkiewicz

    The array SPR imaging (SPRi) technique is well suited to the determination of biomarkers in body fluids, called liquid biopsy. No signal enhancement or analyte preconcentration is required. With the aim of achieving signal enhancement and lowering the cost of a single determination, the replacement of gold-covered chips by silver–gold chips was investigated. The aim of this work was to investigate the analytical characteristics of a biosensor formed on a Ag/Au chip and to compare them with those of a biosensor formed on a gold chip. A biosensor for the determination of cathepsin S (Cath S) was chosen as an example. The biosensor consisted of the linker cysteamine and an immobilized rat monoclonal antibody specific for cathepsin S. Both biosensors exhibited a Langmuirian response to Cath S concentration, with linear response ranging from LOQ to 1.5 ng mL−1. The LOQ is 0.1 ng mL−1 for the biosensor formed on the Ag/Au chip, and 0.22 ng mL−1 for that formed on the gold chip. Recoveries and precision for medium and high Cath S concentrations were acceptable for both biosensors, i.e., precision better than 10% and recoveries within the range 102–105%. However, the results for the lowest Cath S concentration were better for the biosensor formed on the Ag/Au chip (9.4 and 106% for precision and recovery, respectively). Generally, no significant differences in analytical characteristics were observed between the Ag/Au and Au chips. The two biosensors were also compared in the determination of Cath S in real samples. Nine plasma samples from healthy donors and nine from patients with ovarian cancer were analyzed for Cath S concentration with the biosensors formed on Ag/Au and Au chips. The results obtained with the two biosensors were very similar and show no significant differences on the Bland–Altman plot. The Cath S concentration in the blood plasma of ovarian cancer patients was elevated by one order of magnitude as compared with the control (12.6 ± 3.6 vs. 1.6 ± 1.2 ng mL−1).